Literature DB >> 14715042

Pharmacological treatments for persistent non-malignant pain in older persons.

Thorsten Nikolaus1, Andrej Zeyfang.   

Abstract

Persistent non-malignant pain is common, often neglected and under-treated among older persons. Some older adults do not complain because they consider chronic pain to be a characteristic of normal aging. Physicians have concerns regarding adverse effects of pharmacological treatment. The model of the World Health Organization for treatment of cancer pain is generally accepted and also recommended for persistent non-cancer pain. Furthermore, non-pharmacological treatment should complement drug treatment whenever possible. An initial assessment and possible treatment of underlying causes of pain are pertinent. Modern pharmacological pain management is based on non-opioid and opioid analgesics. NSAIDs are among the most widely prescribed class of drugs in the world. The new cyclo-oxygenase-2 inhibitors such as celecoxib and rofecoxib offer an alternative for the treatment of mild-to-moderate pain in patients with a history of gastric ulcers or bleeding. Paracetamol (acetaminophen) is being used widely for the management of mild pain across all age groups as it has moderate adverse effects at therapeutic dosages. For moderate pain, a combination of non-opioid analgesics and opioid analgesics with moderate pain relief properties (e.g. oxycodone, codeine, tramadol and tilidine/naloxone) is recommended. For severe pain, a combination of non-opioid analgesics and opioid analgesics with strong pain relief properties (e.g. morphine, codeine) is recommended. The least toxic means of achieving systemic pain relief should be used. For continuous pain, sustained-release analgesic preparations are recommended. Drugs should be given on a fixed time schedule, and possible adverse effects and interactions should be carefully monitored. Adjuvant drugs, such as antidepressants or anticonvulsants, can be very effective especially in the treatment of certain types of pain, such as in diabetic neuropathy. Effective pain management should result in decreased pain, increased function and improvement in mood and sleep.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715042     DOI: 10.2165/00002512-200421010-00003

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  242 in total

Review 1.  Pain management in the elderly.

Authors:  D B Gordon
Journal:  J Perianesth Nurs       Date:  1999-12       Impact factor: 1.084

2.  FDA fails to reduce accessibility of paracetamol despite 450 deaths a year.

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2002-09-28

Review 3.  Cancer pain relief and palliative care. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1990

4.  Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group.

Authors:  S Ahmedzai; D Brooks
Journal:  J Pain Symptom Manage       Date:  1997-05       Impact factor: 3.612

Review 5.  Group education for rheumatoid arthritis patients.

Authors:  E Taal; J J Rasker; O Wiegman
Journal:  Semin Arthritis Rheum       Date:  1997-06       Impact factor: 5.532

Review 6.  Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs.

Authors:  D E Furst
Journal:  Arthritis Rheum       Date:  1994-01

7.  Topical diclofenac versus placebo: a double blind, randomized clinical trial in patients with osteoarthritis of the knee.

Authors:  D Grace; J Rogers; K Skeith; K Anderson
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

Review 8.  Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials.

Authors:  Jonathan J Deeks; Lesley A Smith; Matthew D Bradley
Journal:  BMJ       Date:  2002-09-21

9.  Changing profile of joint disorders with age: findings from a postal survey of the population of Calderdale, West Yorkshire, United Kingdom.

Authors:  E M Badley; A Tennant
Journal:  Ann Rheum Dis       Date:  1992-03       Impact factor: 19.103

10.  Comparison of antiepileptic drugs tiagabine, lamotrigine, and gabapentin in mouse models of acute, prolonged, and chronic nociception.

Authors:  Tinna M Laughlin; Kevin V Tram; George L Wilcox; Angela K Birnbaum
Journal:  J Pharmacol Exp Ther       Date:  2002-09       Impact factor: 4.030

View more
  15 in total

Review 1.  Buprenorphine 5, 10 and 20 μg/h transdermal patch: a review of its use in the management of chronic non-malignant pain.

Authors:  Greg L Plosker
Journal:  Drugs       Date:  2011-12-24       Impact factor: 9.546

2.  Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine.

Authors:  Barbara Grün; Ulrike Merkel; Klaus-Dieter Riedel; Johanna Weiss; Gerd Mikus
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

3.  Factor structure of the Arthritis-Related Health Belief instrument in ethnically diverse community-dwelling older adults with chronic pain.

Authors:  Juyoung Park; Russell Clement; Nancy Hooyman; Katia Cavalie; Joseph Ouslander
Journal:  J Community Health       Date:  2015-02

4.  Tramadol combined with fentanyl in awake endotracheal intubation.

Authors:  Sai-Ying Wang; Yang Mei; Hui Sheng; Yang Li; Rui Han; Cheng-Xuan Quan; Zhong-Hua Hu; Wen Ouyang; Zhao-Qian Liu; Kai-Ming Duan
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

Review 5.  Late-onset ankylosing spondylitis and related spondylarthropathies: clinical and radiological characteristics and pharmacological treatment options.

Authors:  Eric Toussirot; Daniel Wendling
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  Pharmacological management of renal colic in the older patient.

Authors:  Blayne K Welk; Joel M H Teichman
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

Review 7.  Evaluation of prescription opioids using operant-based pain measures in rats.

Authors:  Drake Morgan; Christy S Carter; Jameson P DuPree; Robert P Yezierski; Charles J Vierck
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

Review 8.  [Non-opioid pain medication in the elderly].

Authors:  H Burkhardt; M Wehling
Journal:  Schmerz       Date:  2015-08       Impact factor: 1.107

9.  Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole.

Authors:  Barbara Grün; Stefanie Krautter; Klaus-Dieter Riedel; Gerd Mikus
Journal:  Br J Clin Pharmacol       Date:  2009-11       Impact factor: 4.335

Review 10.  [Pain treatment in geriatric patients].

Authors:  H D Basler; N Griessinger; U Hankemeier; D Märkert; T Nikolaus; W Sohn
Journal:  Urologe A       Date:  2004-03       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.